Skip to main content
. 2019 Jan 23;14(1):e0210991. doi: 10.1371/journal.pone.0210991

Table 1. Baseline characteristics.

Characteristic All patients Colonized Noncolonized p Value
Number of patients (n, %) 220 (100) 90 (40.9) 130 (59.1)  
Median age (median, range) 60.5 (18–85) 59 (18–85) 61.5 (19–82) ns
Male sex (n, %) 111 (50.5) 52 (57.8) 59 (45.4) ns
Favorable genetic group (n, %) 44 (20.3) 15 (17) 29 (22.5) ns
Intermediate genetic group (n,%) 135 (62.2) 61 (70.5) 74 (57.4) ns
Adverse genetic group (n,%) 37 (17.0) 11 (12.5) 26 (20.1) ns
Peripheral blood blast count* (median, range) 28 (0–98) 31.5 (0–93) 26 (0–98) ns
Bone marrow blast count* (median, range) 60 (5–96) 60 (5–95) 60 (5–96) ns
Lactate dehydrogenase* (median, range) 406.5 (128–4803) 426 (128–3819) 402 (150–4803) ns
Thrombocytes* (median, range) 53 (5–590) 49.5 (10–590) 54.5 (5–548) ns
Leukocytes* (median, range) 14.62 (0.38–340) 14.12 (0.38–340) 15.19 (0.78–311.82) ns
Hemoglobin* (median, range) 9.1 (3.5–16.2) 9.25 (4.3–16) 8,85 (3.5–16.2) ns
C-reactive protein* (median, range) 2.94 (0.02–34.03) 3.28 (0.02–34.03) 2.73 (0.02–29.87) ns

*at time of diagnosis. All p-values reported are two-sided. Statistical significance was defined as p≤0.05.